The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case–control study

Autor: Kahn, Rebecca, Janusz, Cara B., Castro, Marcia C., da Rocha Matos, Aline, Domingues, Carla, Ponmattam, Jamie, Rey-Benito, Gloria, Toscano, Cristiana M., Helena de Oliveira, Lucia, Rearte, Analia, Uriarte, Ignacio Leandro, Baumester, Elsa, Borda, Maria Elena, Diaz Cordoba, Miguel, Facundo Petrina, Juan, Consiglio, Ezequiel, Vizzotti, Carla, Guimarães de Noronha, Tatiana, Gomes Mourão, Maria Paula, Baima Colares, Jeova Keny, Raboni, Sonia Mara, Vanni, Tazio, Guzman, Lely, Pontes Lucena, Adriana Regina Farias, Santolaya, Maria Elena, Urquidi, Cinthya, Cortes, Claudia P., Usedo Lopez, Pedro Pablo, Benitez, Rosana, Latorre, Veronica Menares, Moller Roth, Andrea, Cerda, Iván Brstilo, Santillana, Solange, Abaakouk, Zohra, Caicedo, Angel Paternina, Alvis Guzman, Nelson, Fernandez Mercado, Juan Carlos, de la Hoz Restrepo, Fernando, Santiago Quevedo, David, Rios Oliveros, Sofia, Moyano Romero, Diane
Zdroj: The Lancet Regional Health - Americas; April 2023, Vol. 20 Issue: 1
Abstrakt: As of September 2022, nearly 1.3 billion doses of COVID-19 vaccine products have been administered in Latin America and the Caribbean, where 27% of global COVID-19 deaths have occurred. This study aimed to estimate the effectiveness of COVID-19 vaccines against lab-confirmed COVID-19 related hospitalizations and deaths among adults in Argentina, Brazil, Chile, and Colombia.
Databáze: Supplemental Index